Here are the DEF 14A proxy statements from Aspen Aerogels, Inc. (ASPN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ASPN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASPN filings page.
Aspen Aerogels is holding its 2026 virtual annual stockholder meeting on May 13, 2026, asking investors to elect two directors, ratify KPMG as auditor, approve executive pay and its voting frequency, and support a future move to declassify the board. The board recommends voting for all proposals and choosing “One Year” for say-on-pay frequency.
The proxy also highlights 2025 actions to streamline operations, remove approximately $75 million of structural fixed costs, and strengthen the balance sheet. Aspen ended 2025 with about $159 million in cash and cash equivalents and expects nearly $38 million from a General Motors commercial settlement in Q1 2026, plus potential Plant II asset sales to further reduce debt.